IDEAYA Biosciences Announces US FDA IND-Clearance For IDE849, A Potential First-In-Class DLL3 TOP1 ADC, For A Phase 1 Study In Solid Tumors
May 6 (Reuters) - IDEAYA Biosciences Inc IDYA.O:
IDEAYA BIOSCIENCES ANNOUNCES US FDA IND-CLEARANCE FOR IDE849, A POTENTIAL FIRST-IN-CLASS DLL3 TOP1 ADC, FOR A PHASE 1 STUDY IN SOLID TUMORS
IDEAYA BIOSCIENCES INC - TO START PHASE 1 STUDY IN U.S. BASED ON FDA GUIDANCE
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.